ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon Print
COVID vaccines

Japan moves up COVID booster shots, cuts interval for seniors

Tokyo announces deal with Pfizer for 2m doses of 'vital' oral drug

Japanese Prime Minister Fumio Kishida announced measures on Friday to ramp up efforts to curb the spread of the omicron variant.

TOKYO (Kyodo) -- Japan will shorten the interval for COVID-19 booster shots for senior citizens in general from eight months to seven from February next year, Prime Minister Fumio Kishida said Friday, as the country ramps up efforts to curb the spread of the omicron coronavirus variant.

An eight-month interval has been set "in principle" between the second and third vaccination shots, but the government is seeking to prioritize boosters for the elderly and health care workers.

Kishida also told reporters that Japan has reached a basic agreement with Pfizer to secure 2 million doses of the U.S. pharmaceutical group's orally administered drug for COVID-19. The oral COVID drug is regarded as vital by Japan to fighting the pandemic.

The interval for administering the booster shots for health workers and those at high risk of infection, such as the elderly at nursing homes will be reduced to six months, he added.

Japan started earlier this month administering the third doses of the vaccine developed by Pfizer and BioNTech SE to health care professionals inoculated with their second dose at least eight months ago.

Currently, the health ministry has given the green light for the vaccines from Pfizer and U.S. biotechnology group Moderna to be used as booster shots. The ministry gave fast-track approval to Moderna's vaccine for booster shots on Thursday.

Earlier Friday, Kishida spoke by phone with Albert Bourla, chief executive of Pfizer, and asked the U.S. pharmaceutical company to bring forward Japan's contracted supply of coronavirus vaccine, a government official said.

According to the government's announcement in November, it plans to supply 24 million doses of Pfizer vaccine and 17 million doses of Moderna's to local governments by February.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Discover the all new Nikkei Asia app

  • Take your reading anywhere with offline reading functions
  • Never miss a story with breaking news alerts
  • Customize your reading experience

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more